美国立法者正考虑对生物安全法案进行更改？华大基因投资者关系部回应：没有了解到此消息

Group 1 - The CRO concept stocks experienced a strong rebound, with WuXi AppTec hitting the daily limit and BGI Genomics rising over 2% [1] - U.S. lawmakers are considering changes to the Biosecure Act, which may include increased administrative review for related companies instead of an automatic ban on biopharmaceutical collaborations with Chinese firms [1] - BGI Genomics was specifically named in the U.S. Biosecure Act [3] Group 2 - The U.S. House of Representatives passed the Biosecure Act (H.R.8333) in September [2]